Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale President and CEO sold 5,000 shares at an average $14.95 ($74,725)
  3. 4 Open-market sale President and CEO sold 5,000 shares at an average $15.42 ($77,100)
  4. 4 Open-market sale Chief Scientific Officer sold 12,500 shares at an average $13.93 ($174,075)
  5. 4 Open-market sale President and CEO sold 5,000 shares at an average $13.05 ($65,250)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale President and CEO sold 5,000 shares at $10.11 ($50,550)
  9. 4 Open-market sale President and CEO sold 7,500 shares at an average $9.86 ($73,925)
  10. 4 Open-market sale Chief Accounting & Adm Officer sold 3,361 shares at $10.00 ($33,610)
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale President and CEO sold 7,500 shares at an average $10.91 ($81,800)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale President and CEO sold 7,500 shares at an average $10.96 ($82,200)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale President and CEO sold 7,500 shares at an average $10.21 ($76,550)
  18. 4 Open-market sale Chief Accounting & Adm Officer sold 2,500 shares at $10.42 ($26,050)
  19. 4 Open-market sale Chief Accounting & Adm Officer sold 1,000 shares at $10.39 ($10,390)
  20. 4 Open-market sale President and CEO sold 7,500 shares at an average $10.53 ($78,950)

Page 10 of 14 · 278 filings